β2-Adrenergic agonists bias TLR-2 and NOD2 activated dendritic cells towards inducing an IL-17 immune response.

[1]  Hyun-Dong Chang,et al.  Diversity and flexibility of Th17 effector functions , 2011, Arthritis research & therapy.

[2]  P. Teeling,et al.  Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis , 2010, PloS one.

[3]  H. Jones,et al.  Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-γ by CD4+ T cells , 2010, Brain, Behavior, and Immunity.

[4]  Juan Cheng,et al.  Increased Th17 cells are accompanied by FoxP3(+) Treg cell accumulation and correlated with psoriasis disease severity. , 2010, Clinical immunology.

[5]  S. Gaffen.  The role of interleukin-17 in the pathogenesis of rheumatoid arthritis , 2009, Current rheumatology reports.

[6]  Pilar Romero,et al.  IL‐17‐producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17‐related cytokines , 2009, Journal of leukocyte biology.

[7]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[8]  Ashok Kumar,et al.  The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. , 2009, Inflammation & allergy drug targets.

[9]  G. Maestroni,et al.  Sympathetic nervous modulation of the skin innate and adaptive immune response to peptidoglycan but not lipopolysaccharide: Involvement of β-adrenoceptors and relevance in inflammatory diseases , 2008, Brain, Behavior, and Immunity.

[10]  D. Hommes,et al.  Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. , 2007, Immunity.

[11]  V. Kuchroo,et al.  TH-17 cells in the circle of immunity and autoimmunity , 2007, Nature Immunology.

[12]  W. Maixner,et al.  β2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-κB-independent mechanisms , 2007 .

[13]  B. Ryffel,et al.  Interleukin-17 is a negative regulator of established allergic asthma , 2006, The Journal of experimental medicine.

[14]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[15]  Y. Iwakura,et al.  The IL-23/IL-17 axis in inflammation. , 2006, The Journal of clinical investigation.

[16]  R. D. Hatton,et al.  Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages , 2005, Nature Immunology.

[17]  R. Dziarski,et al.  Peptidoglycan recognition in innate immunity. , 2005, Journal of endotoxin research.

[18]  J. Shellito,et al.  Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae , 2005, The Journal of experimental medicine.

[19]  T. Mcclanahan,et al.  IL-23 drives a pathogenic T cell population that induces autoimmune inflammation , 2005, The Journal of experimental medicine.

[20]  E. Pålsson-McDermott,et al.  Signal transduction by the lipopolysaccharide receptor, Toll‐like receptor‐4 , 2004, Immunology.

[21]  Tomohiro Watanabe,et al.  NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses , 2004, Nature Immunology.

[22]  G. Maestroni.  Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development , 2002, Journal of Neuroimmunology.

[23]  J. Wagner,et al.  Catecholamines Inhibit the Antigen-Presenting Capability of Epidermal Langerhans Cells1 , 2002, The Journal of Immunology.

[24]  H. Weiner,et al.  Potential of β2-Adrenoceptor Agonists as Add-On Therapy for Multiple Sclerosis , 2002, CNS Drugs.

[25]  E. Vizi,et al.  Stimulation of β-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice , 1998, Journal of Neuroimmunology.

[26]  Patrick M Flood,et al.  Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms. , 2007, Cellular signalling.

[27]  G. Maestroni,et al.  Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity. , 2003, Journal of neuroimmunology.

[28]  H. Weiner,et al.  Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol). , 2002, CNS drugs.

[29]  E. Vizi,et al.  Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL-12 production in normal and IL-10 deficient mice. , 1998, Journal of neuroimmunology.